Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...

1 Dallah Hospital Al-Khobar, Al Khobar, Saudi Arabia. 2 StemCells Regenerative and Research Labs Inc. Towli Chowki, Hyderabad, India. 3 Art Haifa Fertility Center, Azizia, Al Khobar, Saudi Arabia. 4 ...

The effect of gut microbiota on carcinogenesis and progression has been demonstrated and arisen wide attention. Notably, specific microbial communities demonstrate dual therapeutic potential in ...

Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new study finds that some women at greater risk can safely avoid radiation. By ...

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows. An international trial found that patients ...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small ...

METIS trial achieved its primary endpoint, showing a statistically significant delay in time to intracranial progression in patients receiving TTFields therapy and best supportive care following ...